SCHEMBL18616409

SCHEMBL18616409

NNc1nc(N)cc(Cc2cc(-c3ccccc3)no2)c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.49
▸ MPO P05164 1/20 0.45
▸ CYP11B1 P15538 4/20 0.43
▸ CYP11B2 P19099 3/20 0.43
▸ NPC1 O15118 8/20 0.42
▸ RAB9A P51151 8/20 0.42
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.42
▸ POLB P06746 1/20 0.41
▸ KCNH2 Q12809 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18619961 0.76 MPO (0.49) MPONPC1RAB9ASMN1; SMN2CYP3A4
SCHEMBL18616406 0.76 NOTUM (0.49) NOTUMMPOCYP11B1CYP11B2NPC1
SCHEMBL18616410 0.75 NOTUM (0.46) NOTUMMPOCYP11B1CYP11B2NPC1
SCHEMBL18616401 0.75 CYP2A6 (0.44) MPOCYP11B1CYP11B2MAPTCYP2C19
SCHEMBL18618791 0.74 MPO (0.55) MPOCYP3A4
SCHEMBL1791868 0.71 NOTUM (0.52) NOTUMCYP11B1CYP11B2NPC1RAB9A
SCHEMBL18616503 0.70 CYP19A1 (0.50) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL1787674 0.70 NOTUM (0.58) NOTUMMPOCYP11B1CYP11B2NPC1
SCHEMBL28670401 0.69 CYP11B1 (0.66) NOTUMCYP11B1CYP11B2NPC1RAB9A
SCHEMBL18616579 0.68 NOS1 (0.36) KCNH2MAPTGAACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040449-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-09 — — WO disclosed
Send feedback